Joshua J Skydel

6PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersClinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsOpen access
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 21, 2026
Commercial price variation in precision oncology testing across US hospitals.

|Feb 27, 2026
Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic Management.

Joshua J Skydel, Betty Hsiao

|Apr 10, 2024
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study.

Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel

|Apr 17, 2021
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.

Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva

|Feb 02, 2021
Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year.

Mallory K Ellingson, Xiaoting Shi, Joshua J Skydel

Pageof 1

Frequent Collaborators

4 joint publications

Joshua D Wallach

4 joint publications

Joseph S Ross

2 joint publications

Reshma Ramachandran

2 joint publications

Maryam Mooghali